02/10/2025 4:28 PM | Calidi Biotherapeutics (Filer)
| Form 8-K/A | |
02/09/2025 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
02/05/2025 5:27 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/28/2025 7:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 3:58 PM | Calidi Biotherapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/10/2025 3:24 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 7:30 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/10/2025 7:30 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 3:01 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
01/03/2025 4:25 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2025 4:27 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for CLDI and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Calidi Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
12/29/2024 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
12/18/2024 8:29 PM | Calidi Biotherapeutics (Issuer) Camaisa Allan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2024 5:13 AM | Calidi Biotherapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
11/29/2024 4:00 PM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/18/2024 7:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 4:02 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/15/2024 5:03 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/14/2024 5:21 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
11/12/2024 4:08 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/28/2024 9:05 AM | Calidi Biotherapeutics (Subject) NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
10/24/2024 4:18 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 8:38 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/23/2024 7:25 AM | Calidi Biotherapeutics (Filer)
| Form 424B5 | |
10/18/2024 4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/18/2024 4:29 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Peoples George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 8:14 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2024 4:05 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/10/2024 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
09/30/2024 5:53 PM | Calidi Biotherapeutics (Issuer) Camaisa Allan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/30/2024 8:10 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 5:10 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/12/2024 5:12 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2024 3:04 PM | Calidi Biotherapeutics (Subject) Funicular Funds, LP (Filed by)
| Form SC 13G | |
08/22/2024 4:16 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/20/2024 5:04 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/13/2024 4:10 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/29/2024 8:15 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry." (Ad) If you missed out on the big boom in Nvidia…
Listen up, because according to Nvidia's own CEO…
Elon Musk’s new technology could help launch an entirely new multitrillion-dollar industry. You MUST act before March 17th. |
07/15/2024 3:58 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2024 3:51 PM | Calidi Biotherapeutics (Issuer) Peoples George (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
07/11/2024 3:53 PM | Calidi Biotherapeutics (Issuer) Peoples George (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/08/2024 3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/05/2024 3:30 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/02/2024 7:20 PM | Calidi Biotherapeutics (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:22 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:12 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:14 PM | Calidi Biotherapeutics (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:16 PM | Calidi Biotherapeutics (Issuer) Leftwich Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/02/2024 7:18 PM | Calidi Biotherapeutics (Issuer) Stewart Alan R. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/26/2024 3:15 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/20/2024 7:56 PM | Calidi Biotherapeutics (Issuer) Jackson Andrew C. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 7:56 PM | Calidi Biotherapeutics (Issuer) Campbell Wendy Pizarro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 7:56 PM | Calidi Biotherapeutics (Issuer) Minev Boris Radoslavov (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/20/2024 7:56 PM | Calidi Biotherapeutics (Issuer) Camaisa Allan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 3:15 PM | Calidi Biotherapeutics (Issuer) Schoeneck James A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/04/2024 4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
05/17/2024 3:35 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/16/2024 4:24 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
05/14/2024 8:01 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/14/2024 3:57 PM | Calidi Biotherapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024 4:00 PM | Calidi Biotherapeutics (Filer)
| Form DEF 14A | |
05/01/2024 11:57 AM | Calidi Biotherapeutics (Subject) Kessler Judd S (Filed by)
| Form SCHEDULE 13D | |
04/19/2024 4:25 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/19/2024 4:20 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/18/2024 4:00 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/17/2024 3:15 PM | Calidi Biotherapeutics (Filer)
| Form 424B4 | |
04/16/2024 11:15 PM | Calidi Biotherapeutics (Filer)
| Form EFFECT | |
04/15/2024 5:31 AM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/08/2024 3:40 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/02/2024 4:29 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
04/01/2024 8:00 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/29/2024 8:47 PM | Calidi Biotherapeutics (Filer)
| Form S-1/A | |
03/18/2024 7:41 AM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/15/2024 4:28 PM | Calidi Biotherapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/12/2024 7:00 PM | Calidi Biotherapeutics (Issuer) LaPre David (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
03/12/2024 4:28 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |
03/12/2024 3:51 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 4:24 PM | Calidi Biotherapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 4:27 PM | Calidi Biotherapeutics (Filer)
| Form 424B3 | |